Lev Pharmaceuticals Posts -- BloggingStocks

Lev Pharmaceuticals posts

Market highlights for next week: Verizon, Boeing and Google reporting

Monday, January 28

Verizon Communications (NYSE: VZ) is reporting Q4 earnings; conference call at 8:30am.
Halliburton Company (NYSE: HAL) is reporting Q4 earnings; conference call at 9am.
Compass Diversified Holdings (NASDAQ: CODI) to hold conference call to discuss the acquisition of Staffmark Investment & Fox Factory.
Warner Chilcott Ltd. (NASDAQ: WCRX) to hold conference call to give 2008 guidance.

Tuesday, January 29

PDUFA date for GlaxoSmithKline plc (ADR) (NYSE: GSK)'s Cervarix, a cervical cancer vaccine.
JetBlue Airways Corporation (NASDAQ: JBLU) to report Q4 earnings; conference call at 10:00am.
United States Steel Corporation (NYSE: X) to report Q4 earnings; conference call at 3:00pm.
Yahoo! Inc. (NASDAQ: YHOO) to report Q4 earnings; conference call at 5:00pm.

Wednesday, January 30

PDUFA date for Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) and Wyeth (NYSE: WYE)' Methylanaltrexone, an opioid receptor antagonists for treatment of opioid-induced constipation.
PDUFA date for Lev Pharmaceuticals, Inc. (OTC: LEVP)'s Cinryze for acute HAE.
Boeing Inc. (NYSE: BA) to report Q4 earnings; conference call at 10:30am.
Altria (NYSE: MO) to report Q4 earnings; conference call at 1:00pm.
Starbucks (NASDAQ: SBUX) to report Q1 earnings; conference call at 5:00pm.

Thursday, January 31

Friday, February 1

Exxon Mobil Corporation (NYSE: XOM) to report Q4 earnings; conference call at 11:00am.
PDUFA date for Axcan Pharma Inc. (NASDAQ: AXCA)'s for Ultrase/Ultrase MT (Pancrelipase) enzyme replacement therapy for treatment of chronic Pancreatitis and Pancreatic Deficiency related to Cystic Fibrosis.

MOST NOTEWORTHY: Gander Mountain, Lev Pharmaceuticals, Intermune, Aetna and Medco Health were today's noteworthy initiations:

Nollenberger initiated shares of Gander Mountain Company (NASDAQ: GMTN) with a Sell rating and $5.00 target, and believes the company's goal of reaching profitability in 2007 could prove overly optimistic.
Lev Pharmaceuticals (OTC: LEVP) was initiated with a Sector Outperformer rating and $3 target at CIBC, as the firm believes Cinryze will likely be approved in 1Q08 and they expect the company to have significant pricing leverage.
JP Morgan resumed coverage of Intermune Inc (NASDAQ: ITMN) with an Overweight rating and expects shares to be driven by the company's pipeline in IPF and HCV.
Aetna Incorporated (NYSE: AET) was initiated with an Outperform rating at Wachovia. The firm feels Aetna is positioned for better growth and higher quality earnings than its peers.
William Blair started shares of Medco Health Solutions Inc (NYSE: MHS) with an Outperform rating, as they believe an aging population, rising health care costs, and an acceleration in new product introductions should increase demand for PBM services over the next five years.

OTHER INITIATIONS:

ABN Amro started shares of Siliconware Precision Industries Company Ltd (NASDAQ: SPIL) and Advanced Semiconductor Engineering Inc (NYSE: ASX) with Buy ratings.
Goldman initiated Silicon Image Inc (NASDAQ: SIMG) with a Sell rating and $4.50 target, and initiated Sigma Designs Inc (NASDAQ: SIGM) and SiRF Technology Holdings Inc (NASDAQ: SIRF) with Neutral ratings and a $43 target and $19 target, respectively.

#	Blogger	Posts
1	Joseph Lazzaro	117
2	Tom Johansmeyer	104
3	Steven Mallas	53
4	Tom Taulli	48
5	Connie Madon	48
6	Mark Fightmaster	37
7	Steven Halpern	37
8	Trey Thoelcke	35
9	Paul Foster	25
10	Zac Bissonnette	25
11	Brian White	24
12	Brent Archer	23
13	Jim Cramer	22
14	Melly Alazraki	22
15	Jon Ogg	22
16	Eric Buscemi	18
17	Michael Fowlkes	15
18	Michael Shulman	13
19	Elizabeth Harrow	12
20	David Schepp	9

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.